Rapid and efficient generation of neurons from Charcot-Marie-Tooth disease (CMT2A) patient IPSCS

被引：0
|
作者：
De La Cruz-Sevilla, Josue [1 ]
Zhou, Yueqin [2 ,3 ]
Bell, Shaughn [2 ,3 ]
Baloh, Robert [2 ,3 ,4 ]
机构：
[1] Calif State Univ Long Beach, CSULongBeach CIRM Stem Cell Internship, Long Beach, CA 90840 USA
[2] Cedars Sinai Med Ctr, Ctr Neural Sci & Med, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA
[4] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2021年 / 26卷 / 01期
关键词：
CMT2A; MFN2; iPSC; Inducible Differentiation; Neurons;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
455
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [31] Myodonic seizures in a patient with Charcot-Marie-Tooth disease
    Piantino, Juan A.
    Torres, Alcy
    PEDIATRIC NEUROLOGY, 2007, 36 (02) : 118 - 120
  • [32] Esophageal Dysmotility in a Patient With Charcot-Marie-Tooth Disease
    Kloub, Mohammad N.
    Okwesili, Byron
    Abushanab, Mohammad
    Haddad, Ahmad
    Anwar, Atheer
    Al-maharmeh, Qusai
    Atiyat, Raed
    Dacosta, Theodore
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2290 - S2290
  • [33] Anaesthetic implications in patient with Charcot-Marie-Tooth disease
    Kapoor, Hemlata
    Shah, Milin
    Desai, Suhani
    INDIAN JOURNAL OF ANAESTHESIA, 2021, 65 (07) : 561 - 562
  • [34] Charcot-Marie-Tooth disease type 2
    Vance, JM
    CHARCOT-MARIE-TOOTH DISORDERS, 1999, 883 : 42 - 46
  • [35] Type 2 Charcot-Marie-Tooth disease
    Combarros-Pascual, O
    REVISTA DE NEUROLOGIA, 2000, 30 (01) : 79 - 81
  • [36] AUTOSOMAL-DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE-2 - INVESTIGATION OF GENETIC-HETEROGENEITY AND MAPPING OF THE CMT2A LOCUS
    VANCE, JM
    DENTON, VP
    OTHMANE, KB
    LENNON, F
    SLAJICH, JM
    DENG, H
    SIDDIQUE, T
    ROSES, AD
    PERICAKVANCE, MA
    NEUROLOGY, 1994, 44 (04) : A293 - A293
  • [37] Dynamin 2 in Charcot-Marie-Tooth Disease
    Tanabe, Kenji
    Takei, Kohji
    ACTA MEDICA OKAYAMA, 2012, 66 (03) : 183 - 190
  • [38] CHARCOT-MARIE-TOOTH SUBTYPE BIOMARKERS AND OUTCOME MEASURES IN SUBJECTS WITH CMT1B, CMT2A, CMT2F AND CMT1X
    Dragon, Amanda
    Reilly, Mary
    Svaren, John
    Scherer, Steven
    Pareyson, Davide
    Herrmann, David
    Shy, Michael E.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S17 - S18
  • [39] TESTING OVERWORK WEAKNESS IN CHARCOT-MARIE-TOOTH (CMT) DISEASE: IS IT TRUE OR FALSE?
    Prada, V
    Mori, L.
    Francini, L.
    Accogli, S.
    Ursino, G.
    Gemelli, C.
    Schizzi, S.
    Grandis, M.
    Bellone, E.
    Mandich, P.
    Schenone, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (03) : 290 - 290
  • [40] RELIABILITY OF THE CMT NEUROPATHY SCORE (SECOND VERSION) IN CHARCOT-MARIE-TOOTH DISEASE
    Murphy, S. M.
    Herrmann, D. N.
    McDermott, M.
    Shy, M. E.
    Reilly, M. M.
    Pareyson, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S93 - S94
12345